NEUROENDOCRINE (NE) TUMORS
Clinical trials for NEUROENDOCRINE (NE) TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE (NE) TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE (NE) TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare gut tumors? phase 2 trial launches
Disease control Not yet recruitingThis phase 2 trial tests a new drug called AUR103 calcium in 30 people with advanced neuroendocrine tumors that have worsened after at least one prior treatment. The goal is to see if the drug can shrink tumors or stop them from growing. Participants take the drug twice daily unt…
Matched conditions: NEUROENDOCRINE (NE) TUMORS
Phase: PHASE2 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
Can learning to manage side effects improve life for neuroendocrine tumor patients?
Knowledge-focused Not yet recruitingThis study looks at whether a therapeutic education program helps patients with neuroendocrine tumors who are taking oral anti-cancer drugs. The researchers will track side effects, treatment adherence, and quality of life in 100 adults over 3 months. The goal is to see if teachi…
Matched conditions: NEUROENDOCRINE (NE) TUMORS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:58 UTC
-
New study aims to reduce harmful side effects in rare cancer patients
Knowledge-focused Not yet recruitingThis study will follow 1,100 people with advanced neuroendocrine tumors (a rare, slow-growing cancer) to see which treatments or treatment sequences cause the fewest long-term side effects. Researchers will track patients for up to 5 years, recording any side effects that last mo…
Matched conditions: NEUROENDOCRINE (NE) TUMORS
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:11 UTC